Who we are
At the Ji Research Group, we are pursuing projects focused on personalized medicine. Specifically, we are interested in using genetic and genomic approaches in oncology to improve targeted cancer therapy development, make accurate prognoses, predict the efficacy of cancer therapy and identify clinically relevant cancer mutations. These projects are aimed at establishing the paradigm for individualized medicine, facilitate the introduction of these approaches into validation clinical studies and thus develop the next generation of cancer diagnostics and treatment.
Using information from your tumor, blood, and saliva samples, we can determine mutations in the genome that are specific to you. We do this by whole genome sequencing and ultrasensitive monitoring of your tumor and response to your treatment in the advancement of precision cancer medicine.
Meet the team
Associate Professor of Medicine (Oncology) in the Stanford University School of Medicine
My research interest is cancer genetics with an emphasis on clinically relevant questions that will improve our understanding of the cancer genetics of clinical phenotype and simultaneously improve patient care in oncology. I have extensive bench research experience in the fields of genome sequencing technology development, human genetic analysis through human genome sequencing and molecular assay development. My research benefits from the various innovations in genomic and genetic technologies that my group has developed.